| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Mortgage Refinance > Flexible Mortgage Could be a Help or a Hurt |
|
Answers - Flexible Mortgage Could be a Help or a Hurt
Flexible mortgages are not for the weak of heart. Choosing this route can be a g According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product amble, but it can also be a great money saving experience. When the interest rat ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s are low, it is smart to lock into a fixed rate; one you know will never rise ev lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. en when the prime rate does. Flexible mortgages become more enticing when the pr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe me rate has moved upward. Flexible rate mortgages start out at a lower rate (oft d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro en significant) than fixed rates. Then depending on how they are set up, the rat ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc is locked in for the first few years. After that initial grace period, things c easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi an get ugly. In the late 70’s many people found their interest rates climbing in nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically o the 20% zone and their payments pushed them right out of their homes. If you a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ re looking to a flexible rate mortgage for the lower interest rate or for the low ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi r payment then keep a few things in mind. 1. The rate you have today is not perm ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nent. It will increase yearly, as long as the rate goes up. 2. You can negotiat dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e the amount a rate can increase each year - .5% or 1% is about standard. This g cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ves you a safeguard incase rates take a dramatic increase. 3. Watch the rates. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen If there is a large increase predicted then it could be a smart time to lock in t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e rate you have by refinancing to a fixed rate. Flexible mortgages can be a mone ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust y saver, but they can also cause financial ruin if they are not handled correctly y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Remember that the rate you are getting is only temporary. It may last for thre . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e years, five years, or just one year, but with the prime rate poised to increase elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip it is likely that flexible mortgages will also see a rise in rates in the future tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Reaching Full Potential Through Positive Influences Your Full Value: Do Your Customers Know It?
|